[1]
“AYUSH-64 as an adjunct to standard care in asymptomatic, mild, and moderate COVID-19: A systematic review and meta-analysis”, IJTK, vol. 22, no. 3, pp. 526–536, Sep. 2023, doi: 10.56042/ijtk.v22i3.5730.